GeoVax Labs Inc
GOVX0.740USD
+0.015+2.13%
交易中 （美东）报价延迟15分钟
11.79M总市值
亏损市盈率 TTM
关于 GeoVax Labs Inc 公司
GeoVax Labs, Inc. 是一家临床阶段的生物技术公司，利用专有平台开发针对传染病和实体瘤癌症的人类疫苗和免疫疗法。其产品线包括正在进行的 Covid-19 疫苗人体临床试验和针对晚期头颈癌的基因导向疗法。其其他研发项目包括针对 Mpox 和天花、出血热病毒（埃博拉扎伊尔病毒、埃博拉苏丹病毒和马尔堡病毒）、寨卡病毒和疟疾的预防性疫苗，以及针对多种实体瘤的免疫疗法。该公司的全资、共同拥有和授权的知识产权组合包括 155 多项已授予或正在申请的专利申请，分布在 24 个专利系列中。其候选产品包括 GEO-CM04S1、GEO-CM02、Gedeptin、MVA-VLP-MUC1、GEO-ZM02 等。其主要的传染病候选药物是 GEO-CM04S1，这是一种针对高危免疫功能低下患者群体的 COVID-19 疫苗。
公司简介
公司代码GOVX
公司名称GeoVax Labs Inc
上市日期Apr 04, 1994
CEOMr. David A. Dodd
员工数量17
证券类型Ordinary Share
年结日Apr 04
公司地址1900 Lake Park Drive
城市SMYRNA
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编30080
电话16783847220
网址https://www.geovax.com/
公司代码GOVX
上市日期Apr 04, 1994
CEOMr. David A. Dodd
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. David A. Dodd
Mr. David A. Dodd
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
36.66K
--
Mr. Mark W. Reynolds, CPA
Mr. Mark W. Reynolds, CPA
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
14.01K
+94.27%
Dr. Robert T. McNally, Ph.D.
Dr. Robert T. McNally, Ph.D.
Independent Director
Independent Director
3.60K
--
Dr. Randal D. Chase, Ph.D.
Dr. Randal D. Chase, Ph.D.
Independent Director
Independent Director
2.44K
--
Mr. Dean G. Kollintzas
Mr. Dean G. Kollintzas
Independent Director
Independent Director
800.00
--
Dr. Kelly T. Mckee, M.D.
Dr. Kelly T. Mckee, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Jayne Morgan, M.D.
Dr. Jayne Morgan, M.D.
Independent Director
Independent Director
--
--
Dr. Mark J. Newman, Ph.D.
Dr. Mark J. Newman, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. John N. (Jack) Spencer, Jr.
Mr. John N. (Jack) Spencer, Jr.
Independent Director
Independent Director
--
--
Dr. John W. Sharkey, Ph.D.
Dr. John W. Sharkey, Ph.D.
Vice President - Business Development
Vice President - Business Development
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. David A. Dodd
Mr. David A. Dodd
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
36.66K
--
Mr. Mark W. Reynolds, CPA
Mr. Mark W. Reynolds, CPA
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
14.01K
+94.27%
Dr. Robert T. McNally, Ph.D.
Dr. Robert T. McNally, Ph.D.
Independent Director
Independent Director
3.60K
--
Dr. Randal D. Chase, Ph.D.
Dr. Randal D. Chase, Ph.D.
Independent Director
Independent Director
2.44K
--
Mr. Dean G. Kollintzas
Mr. Dean G. Kollintzas
Independent Director
Independent Director
800.00
--
Dr. Kelly T. Mckee, M.D.
Dr. Kelly T. Mckee, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 7月9日 周三
更新时间: 7月9日 周三
持股股东
股东类型
持股股东
持股股东
占比
L1 Capital Global Opportunities Master Fund Ltd.
5.82%
Armistice Capital LLC
2.61%
The Vanguard Group, Inc.
0.45%
Geode Capital Management, L.L.C.
0.38%
UBS Switzerland AG
0.31%
Other
90.43%
持股股东
持股股东
占比
L1 Capital Global Opportunities Master Fund Ltd.
5.82%
Armistice Capital LLC
2.61%
The Vanguard Group, Inc.
0.45%
Geode Capital Management, L.L.C.
0.38%
UBS Switzerland AG
0.31%
Other
90.43%
股东类型
持股股东
占比
Corporation
5.82%
Hedge Fund
2.69%
Investment Advisor
0.93%
Investment Advisor/Hedge Fund
0.50%
Individual Investor
0.49%
Bank and Trust
0.31%
Research Firm
0.22%
Other
89.05%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
48
1.25M
5.13%
+94.59K
2025Q1
48
1.22M
8.27%
+83.76K
2024Q4
47
829.80K
9.13%
+330.71K
2024Q3
46
493.58K
6.02%
-230.53K
2024Q2
44
230.87K
6.14%
-94.40K
2024Q1
48
277.50K
12.08%
-7.33K
2023Q4
47
235.03K
12.03%
+67.17K
2023Q3
51
129.03K
7.28%
-172.28K
2023Q2
50
129.35K
7.40%
-168.66K
2023Q1
50
126.42K
8.79%
-177.21K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Armistice Capital LLC
662.88K
2.63%
+167.30K
+33.76%
Mar 31, 2025
The Vanguard Group, Inc.
115.16K
0.46%
+64.01K
+125.16%
Mar 31, 2025
Geode Capital Management, L.L.C.
97.04K
0.39%
+6.90K
+7.66%
Mar 31, 2025
UBS Switzerland AG
77.64K
0.31%
+65.10K
+519.30%
Mar 31, 2025
Morgan Stanley Smith Barney LLC
75.12K
0.3%
+75.00K
+62500.00%
Mar 31, 2025
Dodd (David A)
36.66K
0.24%
--
--
Jun 25, 2025
BlackRock Institutional Trust Company, N.A.
27.57K
0.11%
--
--
Mar 31, 2025
Morgan Stanley & Co. LLC
27.05K
0.11%
+27.05K
--
Mar 31, 2025
Jane Street Capital, L.L.C.
25.83K
0.1%
+25.83K
--
Mar 31, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Jan 29, 2024
Merger
15<1
Jan 29, 2024
Merger
15<1
Jan 29, 2024
Merger
15<1
Jan 29, 2024
Merger
15<1
公告日期
类型
比率
Jan 29, 2024
Merger
15<1
Jan 29, 2024
Merger
15<1
Jan 29, 2024
Merger
15<1
Jan 29, 2024
Merger
15<1
